Literature DB >> 2260538

Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960-1984.

M Thörn1, R Bergström, H O Adami, U Ringborg.   

Abstract

This study was based on 15,376 patients in Sweden with cutaneous malignant melanoma diagnosed during the 25-year period 1960-1984. Trunk melanoma increased substantially during that period among men, with age-standardized rates rising from 1.1 to 7.0 per 10(5). Among women, the greatest increases occurred in melanoma of the upper extremity (rising from 0.4 to 2.3), lower extremity (rising from 1.6 to 4.4), and trunk (rising form 0.6 to 3.1), but the rates for the latter two sites seemed to level off after 1978. Multivariate analyses showed that models based on a common parameter ("drift"), including linear birth cohort and/or time periods effects, were significantly superior to simple age models for explaining incidence trends for each separate site. Further, in men with melanoma of the trunk and upper and lower extremities, birth cohort effects had significant effects compared with drift. In contrast, in women, time period effects were a significant improvement on drift for melanoma of the trunk and lower extremity. The relative risk of malignant melanoma among men leveled off in later-born cohorts for all separate sites. A similar trend was found in women, except for melanomas of the trunk, in which the increase in relative risk persisted. The results indicate sex-specific differences in temporal trends of exposure to factors causing malignant melanoma.

Entities:  

Mesh:

Year:  1990        PMID: 2260538     DOI: 10.1093/oxfordjournals.aje.a115749

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  13 in total

1.  Rising melanoma incidence rates of the trunk among younger women in the United States.

Authors:  Porcia T Bradford; William F Anderson; Mark P Purdue; Alisa M Goldstein; Margaret A Tucker
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-09       Impact factor: 4.254

2.  Recent cohort trends in malignant melanoma by anatomic site in the United States.

Authors:  L K Dennis; E White; J A Lee
Journal:  Cancer Causes Control       Date:  1993-03       Impact factor: 2.506

3.  Temporal trends in the incidence of cutaneous malignant melanoma among Caucasians in the San Francisco-Oakland MSA.

Authors:  P L Horn-Ross; E A Holly; S R Brown; D A Aston
Journal:  Cancer Causes Control       Date:  1991-09       Impact factor: 2.506

4.  Melanoma: linked temporal and latitude changes in the United States.

Authors:  J A Lee; J Scotto
Journal:  Cancer Causes Control       Date:  1993-09       Impact factor: 2.506

5.  Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site.

Authors:  Y T Chen; T Zheng; T R Holford; M Berwick; R Dubrow
Journal:  Cancer Causes Control       Date:  1994-07       Impact factor: 2.506

Review 6.  Early detection and prevention of cutaneous malignant melanoma: emphasis on Swedish activities.

Authors:  U Ringborg; B Lagerlöf; M Broberg; E Månsson-Brahme; A Platz; M Thörn
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

Review 7.  Melanoma and sunburn.

Authors:  D Whiteman; A Green
Journal:  Cancer Causes Control       Date:  1994-11       Impact factor: 2.506

8.  Trends in mortality rates from malignant melanoma in Sweden 1953-1987 and forecasts up to 2007.

Authors:  M Thörn; P Sparén; R Bergström; H O Adami
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

9.  Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden.

Authors:  C Wassberg; M Thörn; J Yuen; U Ringborg; T Hakulinen
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

10.  Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden.

Authors:  M Thörn; F Pontén; R Bergström; P Sparén; H O Adami
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.